_id

690da7d2ccc777a4e85d079e

Ticker

AARD

Name

Aardvark Therapeutics, Inc. Common Stock

Exchange

NASDAQ

Address

4370 La Jolla Village Drive, San Diego, CA, United States, 92122

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://aardvarktherapeutics.com

Description

Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Its lead product candidate is ARD-101, an oral gut-restricted small-molecule agonist of certain targeting bitter taste receptors expressed in the gut lumen, which is in the Phase 3 clinical trial for hyperphagia associated with Prader-Willi Syndrome, as well as in the Phase 2 clinical trial for hyperphagia associated with acquired hypothalamic obesity resultant from the treatment of craniopharyngioma, including surgery or radiation. The company is also developing ARD-201, which is in the Phase 1 clinical trial for the treatment of obesity. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.

Last Close

15.55

Volume

119604

Current Price

15.06

Change

-0.46

Last Updated

2026-01-21T18:12:44.690Z

Image

data:image/webp;base64,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

Ipo Date

2025-02-13T00:00:00.000Z

Market Cap

337921184

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.984

Sentiment Sources

1

Rating

4.5

Target Price

32.7

Strong Buy

2

Buy

2

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

10000

Gross Profit

-10000

Operating Expenses

17693000

Operating Income

-17703000

Interest Expense

-

Pretax Income

-16315999

Net Income

-16315999

Eps

-0.7514094915790644

Dividends Per Share

-

Shares Outstanding

21773272

Income Tax Expense

-

EBITDA

-16306000

Operating Margin

-

Total Other Income Expense Net

1387000

Cash

39285000

Short Term Investments

87065000

Receivables

-

Inventories

-

Total Current Assets

129207000

Property Plant Equipment

439000

Total Assets

133229000

Payables

4444000

Short Term Debt

429000

Long Term Debt

-

Total Liabilities

10852000

Equity

122377000

Bs_currency_symbol

USD

Depreciation

10000

Change In Working Capital

-999000

Cash From Operations

-18517000

Capital Expenditures

4000

Cash From Investing

29246000

Cash From Financing

2558000

Net Change In Cash

13287000

Cf_currency_symbol

USD

PE

-

PB

2.6721581790695965

ROE

-13.33256984564093

ROA

-12.246582200571948

FCF

-18521000

Fcf Percent

-

Piotroski FScore

1

Health Score

35

Deep Value Investing Score

4

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

4.3

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

3

Net Net Investing Score

2.5

Quality Investing Score

3

Value Investing Score

4.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

10000

Quarters > 0 > income Statement > gross Profit

-10000

Quarters > 0 > income Statement > operating Expenses

17693000

Quarters > 0 > income Statement > operating Income

-17703000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-16315999

Quarters > 0 > income Statement > net Income

-16315999

Quarters > 0 > income Statement > eps

-0.7514094915790644

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

21713858

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-16306000

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

1387000

Quarters > 0 > income Statement > currency_symbol

USD

Quarters > 0 > balance Sheet > cash

39285000

Quarters > 0 > balance Sheet > short Term Investments

87065000

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

129207000

Quarters > 0 > balance Sheet > property Plant Equipment

439000

Quarters > 0 > balance Sheet > total Assets

133229000

Quarters > 0 > balance Sheet > payables

4444000

Quarters > 0 > balance Sheet > short Term Debt

429000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

10852000

Quarters > 0 > balance Sheet > equity

122377000

Quarters > 0 > balance Sheet > currency_symbol

USD

Quarters > 0 > cash Flow > net Income

-16315999

Quarters > 0 > cash Flow > depreciation

10000

Quarters > 0 > cash Flow > change In Working Capital

-999000

Quarters > 0 > cash Flow > cash From Operations

-18517000

Quarters > 0 > cash Flow > capital Expenditures

4000

Quarters > 0 > cash Flow > cash From Investing

29246000

Quarters > 0 > cash Flow > cash From Financing

2558000

Quarters > 0 > cash Flow > net Change In Cash

13287000

Quarters > 0 > cash Flow > currency_symbol

USD

Quarters > 0 > ratios > PE

-0.7514094915790644

Quarters > 0 > ratios > PB

2.6721581790695965

Quarters > 0 > ratios > ROE

-13.33256984564093

Quarters > 0 > ratios > ROA

-12.246582200571948

Quarters > 0 > ratios > FCF

-18521000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

35

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

-

Quarters > 1 > income Statement > gross Profit

-

Quarters > 1 > income Statement > operating Expenses

15848000

Quarters > 1 > income Statement > operating Income

-15848000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-14367000

Quarters > 1 > income Statement > net Income

-14367000

Quarters > 1 > income Statement > eps

-0.6623705785196361

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

21690275

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-15837000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

1481000

Quarters > 1 > income Statement > currency_symbol

USD

Quarters > 1 > balance Sheet > cash

25998000

Quarters > 1 > balance Sheet > short Term Investments

115822000

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

144768000

Quarters > 1 > balance Sheet > property Plant Equipment

522000

Quarters > 1 > balance Sheet > total Assets

147475000

Quarters > 1 > balance Sheet > payables

5056000

Quarters > 1 > balance Sheet > short Term Debt

417000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

10550000

Quarters > 1 > balance Sheet > equity

136925000

Quarters > 1 > balance Sheet > currency_symbol

USD

Quarters > 1 > cash Flow > net Income

-14367000

Quarters > 1 > cash Flow > depreciation

-620000

Quarters > 1 > cash Flow > change In Working Capital

4385000

Quarters > 1 > cash Flow > cash From Operations

-9844000

Quarters > 1 > cash Flow > capital Expenditures

91000

Quarters > 1 > cash Flow > cash From Investing

9409000

Quarters > 1 > cash Flow > cash From Financing

-71000

Quarters > 1 > cash Flow > net Change In Cash

-506000

Quarters > 1 > cash Flow > currency_symbol

USD

Quarters > 1 > ratios > PE

-0.6623705785196361

Quarters > 1 > ratios > PB

2.3856530326821255

Quarters > 1 > ratios > ROE

-10.492605440934819

Quarters > 1 > ratios > ROA

-9.741990167825056

Quarters > 1 > ratios > FCF

-9935000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

35

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

5000

Quarters > 2 > income Statement > gross Profit

-5000

Quarters > 2 > income Statement > operating Expenses

10470000

Quarters > 2 > income Statement > operating Income

-10470000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-9310000

Quarters > 2 > income Statement > net Income

-9310000

Quarters > 2 > income Statement > eps

-0.7055853713584481

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

13194718

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-10465000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

1160000

Quarters > 2 > income Statement > currency_symbol

USD

Quarters > 2 > balance Sheet > cash

26504000

Quarters > 2 > balance Sheet > short Term Investments

124756000

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

154554000

Quarters > 2 > balance Sheet > property Plant Equipment

628000

Quarters > 2 > balance Sheet > total Assets

157025000

Quarters > 2 > balance Sheet > payables

2556000

Quarters > 2 > balance Sheet > short Term Debt

390000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

6336000

Quarters > 2 > balance Sheet > equity

150689000

Quarters > 2 > balance Sheet > currency_symbol

USD

Quarters > 2 > cash Flow > net Income

-9310000

Quarters > 2 > cash Flow > depreciation

5000

Quarters > 2 > cash Flow > change In Working Capital

-2357000

Quarters > 2 > cash Flow > cash From Operations

-11388000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-112624000

Quarters > 2 > cash Flow > cash From Financing

88875000

Quarters > 2 > cash Flow > net Change In Cash

-35137000

Quarters > 2 > cash Flow > currency_symbol

USD

Quarters > 2 > ratios > PE

-0.7055853713584481

Quarters > 2 > ratios > PB

1.318692493015416

Quarters > 2 > ratios > ROE

-6.17828773168579

Quarters > 2 > ratios > ROA

-5.928992198694476

Quarters > 2 > ratios > FCF

-11388000

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

34

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

0

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

-

Quarters > 3 > income Statement > operating Expenses

9450000

Quarters > 3 > income Statement > operating Income

-9450000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-8779000

Quarters > 3 > income Statement > net Income

-8779000

Quarters > 3 > income Statement > eps

-0.6800541037690211

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

12909267

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-9442000

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

671000

Quarters > 3 > income Statement > currency_symbol

USD

Quarters > 3 > balance Sheet > cash

61641000

Quarters > 3 > balance Sheet > short Term Investments

12022000

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

74137000

Quarters > 3 > balance Sheet > property Plant Equipment

735000

Quarters > 3 > balance Sheet > total Assets

77507000

Quarters > 3 > balance Sheet > payables

2298000

Quarters > 3 > balance Sheet > short Term Debt

338000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

132150000

Quarters > 3 > balance Sheet > equity

-54643000

Quarters > 3 > balance Sheet > currency_symbol

USD

Quarters > 3 > cash Flow > net Income

-8779000

Quarters > 3 > cash Flow > depreciation

-121000

Quarters > 3 > cash Flow > change In Working Capital

815000

Quarters > 3 > cash Flow > cash From Operations

-7727000

Quarters > 3 > cash Flow > capital Expenditures

6000

Quarters > 3 > cash Flow > cash From Investing

-11895000

Quarters > 3 > cash Flow > cash From Financing

-1014000

Quarters > 3 > cash Flow > net Change In Cash

-20636000

Quarters > 3 > cash Flow > currency_symbol

USD

Quarters > 3 > ratios > PE

-0.6800541037690211

Quarters > 3 > ratios > PB

-3.5578859326903727

Quarters > 3 > ratios > ROE

16.06610178796918

Quarters > 3 > ratios > ROA

-11.326718877004657

Quarters > 3 > ratios > FCF

-7733000

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

27

Annuals > 0 > quarter

2024-12-31

Annuals > 0 > income Statement > revenue

0

Annuals > 0 > income Statement > cost Of Revenue

16000

Annuals > 0 > income Statement > gross Profit

-16000

Annuals > 0 > income Statement > operating Expenses

22785000

Annuals > 0 > income Statement > operating Income

-22785000

Annuals > 0 > income Statement > interest Expense

-

Annuals > 0 > income Statement > pretax Income

-20588000

Annuals > 0 > income Statement > net Income

-20588000

Annuals > 0 > income Statement > eps

-1.5948233156847713

Annuals > 0 > income Statement > dividends Per Share

-

Annuals > 0 > income Statement > shares Outstanding

12909267

Annuals > 0 > income Statement > income Tax Expense

-

Annuals > 0 > income Statement > EBITDA

-22652000

Annuals > 0 > income Statement > operating Margin

-

Annuals > 0 > income Statement > total Other Income Expense Net

2197000

Annuals > 0 > income Statement > currency_symbol

USD

Annuals > 0 > balance Sheet > cash

61641000

Annuals > 0 > balance Sheet > short Term Investments

12022000

Annuals > 0 > balance Sheet > receivables

-

Annuals > 0 > balance Sheet > inventories

-

Annuals > 0 > balance Sheet > total Current Assets

74137000

Annuals > 0 > balance Sheet > property Plant Equipment

735000

Annuals > 0 > balance Sheet > total Assets

77507000

Annuals > 0 > balance Sheet > payables

2298000

Annuals > 0 > balance Sheet > short Term Debt

338000

Annuals > 0 > balance Sheet > long Term Debt

-

Annuals > 0 > balance Sheet > total Liabilities

132150000

Annuals > 0 > balance Sheet > equity

-54643000

Annuals > 0 > balance Sheet > currency_symbol

USD

Annuals > 0 > cash Flow > net Income

-20588000

Annuals > 0 > cash Flow > depreciation

16000

Annuals > 0 > cash Flow > change In Working Capital

1573000

Annuals > 0 > cash Flow > cash From Operations

-18087000

Annuals > 0 > cash Flow > capital Expenditures

109000

Annuals > 0 > cash Flow > cash From Investing

-11998000

Annuals > 0 > cash Flow > cash From Financing

81991000

Annuals > 0 > cash Flow > net Change In Cash

51906000

Annuals > 0 > cash Flow > currency_symbol

USD

Annuals > 0 > ratios > PE

-1.5948233156847713

Annuals > 0 > ratios > PB

-3.5578859326903727

Annuals > 0 > ratios > ROE

37.67728711820361

Annuals > 0 > ratios > ROA

-26.562762073103073

Annuals > 0 > ratios > FCF

-18196000

Annuals > 0 > ratios > Piotroski FScore

0

Annuals > 0 > ratios > fcf Percent

-

Annuals > 0 > health Score

30

Annuals > 1 > quarter

2023-12-31

Annuals > 1 > income Statement > revenue

0

Annuals > 1 > income Statement > cost Of Revenue

97000

Annuals > 1 > income Statement > gross Profit

-97000

Annuals > 1 > income Statement > operating Expenses

7415000

Annuals > 1 > income Statement > operating Income

-7415000

Annuals > 1 > income Statement > interest Expense

-

Annuals > 1 > income Statement > pretax Income

-7208000

Annuals > 1 > income Statement > net Income

-7208000

Annuals > 1 > income Statement > eps

-0.5583585807002055

Annuals > 1 > income Statement > dividends Per Share

-

Annuals > 1 > income Statement > shares Outstanding

12909267

Annuals > 1 > income Statement > income Tax Expense

-

Annuals > 1 > income Statement > EBITDA

-6653000

Annuals > 1 > income Statement > operating Margin

-

Annuals > 1 > income Statement > total Other Income Expense Net

207000

Annuals > 1 > income Statement > currency_symbol

USD

Annuals > 1 > balance Sheet > cash

9735000

Annuals > 1 > balance Sheet > short Term Investments

254000

Annuals > 1 > balance Sheet > receivables

-

Annuals > 1 > balance Sheet > inventories

-

Annuals > 1 > balance Sheet > total Current Assets

10368000

Annuals > 1 > balance Sheet > property Plant Equipment

155000

Annuals > 1 > balance Sheet > total Assets

10536000

Annuals > 1 > balance Sheet > payables

1035000

Annuals > 1 > balance Sheet > short Term Debt

112000

Annuals > 1 > balance Sheet > long Term Debt

-

Annuals > 1 > balance Sheet > total Liabilities

45338000

Annuals > 1 > balance Sheet > equity

-34802000

Annuals > 1 > balance Sheet > currency_symbol

USD

Annuals > 1 > cash Flow > net Income

-7208000

Annuals > 1 > cash Flow > depreciation

97000

Annuals > 1 > cash Flow > change In Working Capital

-81000

Annuals > 1 > cash Flow > cash From Operations

-5824000

Annuals > 1 > cash Flow > capital Expenditures

0

Annuals > 1 > cash Flow > cash From Investing

-

Annuals > 1 > cash Flow > cash From Financing

0

Annuals > 1 > cash Flow > net Change In Cash

-5824000

Annuals > 1 > cash Flow > currency_symbol

USD

Annuals > 1 > ratios > PE

-0.5583585807002055

Annuals > 1 > ratios > PB

-5.586275530716626

Annuals > 1 > ratios > ROE

20.71145336474915

Annuals > 1 > ratios > ROA

-68.41305998481397

Annuals > 1 > ratios > FCF

-5824000

Annuals > 1 > ratios > Piotroski FScore

0

Annuals > 1 > ratios > fcf Percent

-

Annuals > 1 > health Score

30

Annuals > 2 > quarter

2022-12-31

Annuals > 2 > income Statement > revenue

0

Annuals > 2 > income Statement > cost Of Revenue

110000

Annuals > 2 > income Statement > gross Profit

-110000

Annuals > 2 > income Statement > operating Expenses

11363000

Annuals > 2 > income Statement > operating Income

-11363000

Annuals > 2 > income Statement > interest Expense

-

Annuals > 2 > income Statement > pretax Income

-13564000

Annuals > 2 > income Statement > net Income

-13564000

Annuals > 2 > income Statement > eps

-1.393640298603154

Annuals > 2 > income Statement > dividends Per Share

-

Annuals > 2 > income Statement > shares Outstanding

9732784

Annuals > 2 > income Statement > income Tax Expense

-

Annuals > 2 > income Statement > EBITDA

-9764000

Annuals > 2 > income Statement > operating Margin

-

Annuals > 2 > income Statement > total Other Income Expense Net

-2201000

Annuals > 2 > income Statement > currency_symbol

USD

Annuals > 2 > balance Sheet > cash

15559000

Annuals > 2 > balance Sheet > short Term Investments

546000

Annuals > 2 > balance Sheet > receivables

-

Annuals > 2 > balance Sheet > inventories

-

Annuals > 2 > balance Sheet > total Current Assets

16491000

Annuals > 2 > balance Sheet > property Plant Equipment

252000

Annuals > 2 > balance Sheet > total Assets

16757000

Annuals > 2 > balance Sheet > payables

259000

Annuals > 2 > balance Sheet > short Term Debt

100000

Annuals > 2 > balance Sheet > long Term Debt

-

Annuals > 2 > balance Sheet > total Liabilities

44680000

Annuals > 2 > balance Sheet > equity

-27923000

Annuals > 2 > balance Sheet > currency_symbol

USD

Annuals > 2 > cash Flow > net Income

-13564000

Annuals > 2 > cash Flow > depreciation

110000

Annuals > 2 > cash Flow > change In Working Capital

-1311000

Annuals > 2 > cash Flow > cash From Operations

-10543000

Annuals > 2 > cash Flow > capital Expenditures

0

Annuals > 2 > cash Flow > cash From Investing

-1000000

Annuals > 2 > cash Flow > cash From Financing

225000

Annuals > 2 > cash Flow > net Change In Cash

-11318000

Annuals > 2 > cash Flow > currency_symbol

USD

Annuals > 2 > ratios > PE

-1.393640298603154

Annuals > 2 > ratios > PB

-5.2492829223221005

Annuals > 2 > ratios > ROE

48.57644235934534

Annuals > 2 > ratios > ROA

-80.94527660082353

Annuals > 2 > ratios > FCF

-10543000

Annuals > 2 > ratios > Piotroski FScore

0

Annuals > 2 > ratios > fcf Percent

-

Annuals > 2 > health Score

30

Valuation > metrics > PE

-0.7514094915790644

Valuation > metrics > PB

2.6721581790695965

Valuation > final Score

80

Valuation > verdict

Fair

Profitability > metrics > ROE

-13.33256984564093

Profitability > metrics > ROA

-12.627798029518525

Profitability > metrics > Net Margin

-

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.08867679384198011

Risk > metrics > Interest Coverage

-1770.4770477047705

Risk > final Score

-7022

Risk > verdict

High

Liquidity > metrics > Current Ratio

-

Liquidity > metrics > Quick Ratio

-

Liquidity > final Score

50

Liquidity > verdict

Weak

Prev Valuations > 0

80

Prev Valuations > 1

80

Prev Valuations > 2

50

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

32

Prev Risks > 0

17

Prev Risks > 1

24

Prev Risks > 2

-27

Prev Liquidities > 0

50

Prev Liquidities > 1

50

Prev Liquidities > 2

50

Updated At

2026-01-21T18:12:45.434Z

Earnings History > 0 > period

2026-03-31

Earnings History > 0 > report Date

2026-04-06

Earnings History > 0 > date

2026-03-31

Earnings History > 0 > before After Market

-

Earnings History > 0 > currency

-

Earnings History > 0 > eps Actual

0

Earnings History > 0 > eps Estimate

-0.8

Earnings History > 0 > eps Difference

0.8

Earnings History > 0 > surprise Percent

100

Earnings History > 1 > period

2025-09-30

Earnings History > 1 > report Date

2025-11-13

Earnings History > 1 > date

2025-09-30

Earnings History > 1 > before After Market

-

Earnings History > 1 > currency

-

Earnings History > 1 > eps Actual

-0.75

Earnings History > 1 > eps Estimate

-0.77

Earnings History > 1 > eps Difference

0.02

Earnings History > 1 > surprise Percent

2.5974

Earnings History > 2 > period

2025-06-30

Earnings History > 2 > report Date

2025-08-14

Earnings History > 2 > date

2025-06-30

Earnings History > 2 > before After Market

AfterMarket

Earnings History > 2 > currency

-

Earnings History > 2 > eps Actual

-0.6623

Earnings History > 2 > eps Estimate

-0.68

Earnings History > 2 > eps Difference

0.0177

Earnings History > 2 > surprise Percent

2.6029

Earnings History > 3 > period

2025-03-31

Earnings History > 3 > report Date

2025-05-14

Earnings History > 3 > date

2025-03-31

Earnings History > 3 > before After Market

AfterMarket

Earnings History > 3 > currency

-

Earnings History > 3 > eps Actual

-0.71

Earnings History > 3 > eps Estimate

-0.7

Earnings History > 3 > eps Difference

-0.01

Earnings History > 3 > surprise Percent

-1.4286

Earnings History > 4 > period

2024-12-31

Earnings History > 4 > report Date

2025-03-31

Earnings History > 4 > date

2024-12-31

Earnings History > 4 > before After Market

-

Earnings History > 4 > currency

-

Earnings History > 4 > eps Actual

-0.435

Earnings History > 4 > eps Estimate

-0.2

Earnings History > 4 > eps Difference

-0.235

Earnings History > 4 > surprise Percent

-117.5